CENTOGENE N.V.

CNTG
Delayed Quote. Delayed  - 11/23 04:00:00 pm
11.42USD -0.70%
Prev.11.5000
Open11.5900
High11.7900
Low11.2200
Volume104 208
Latest news
11/13
11/13
11/09
11/09
Chart CENTOGENE N.V.
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBearishBearish
Resistance13,316,016,7
Spread/Res.-14%-29%-32%
Spread/Supp.10%23%21%
Support10,49,309,44
Financials
Sales 2020 80,0 M 94,7 M 94,7 M
Net income 2020 -29,6 M -35,0 M -35,0 M
Net cash 2020 8,05 M 9,53 M 9,53 M
P/E ratio 2020 -6,70x
Yield 2020 -
Capitalization 212 M 251 M 251 M
EV / Sales 2020 2,55x
EV / Sales 2021 3,21x
Nbr of Employees 440
Free-Float 38,2%
Company
Centogene BV is a Germany-based company engaged in the rare disease market. It focuses on transforming clinical, genetic and biochemical data into medical solutions for patients, physicians and pharmaceutical companies. The Company provides the full spectrum of methods and technology for human...

>> Read more
Sector :
Biotechnology & Medical Research - NEC
Calendar :
2021-04-29 Earnings Release
Trading Rating :
Investor Rating : -

Income Statement Evolution
Consensus
Mean consensus BUY
Number of Analysts 4
Average target price 17,68 €
Last Close Price 9,70 €
Spread / Highest target 110%
Spread / Average Target 82,3%
Spread / Lowest Target 30,9%